Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 9.46x is 149% above its 4-year average of -19.23x, near the high end of its 4-year range (-22055.00x–38.15x).
246.53% above its 12-month average of -6.46x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -24.71x.
INTEREST COVERAGE RATIO
9.46x
INTEREST COVERAGE RATIO AVG TTM
-6.46x
INTEREST COVERAGE RATIO AVG 3Y
-20.94x
INTEREST COVERAGE RATIO AVG 5Y
-19.23x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+246.53%
CURRENT VS 3Y AVG
+145.18%
CURRENT VS 5Y AVG
+149.19%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
+248.39%
vs the sector median at left
Atara Biotherapeutics, Inc.
Market Cap
$87.85M
Interest Coverage Ratio
9.46x
TTM Avg
-6.46x
3Y Avg
-20.94x
5Y Avg
-19.23x
Market Cap
$87.96M
Interest Coverage Ratio
40.06x
TTM Avg
25.10x
3Y Avg
22.17x
5Y Avg
18.57x
Market Cap
$87.27M
Interest Coverage Ratio
-74.92x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$89.44M
Interest Coverage Ratio
-22.29x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$85.86M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$90.20M
Interest Coverage Ratio
3.76x
TTM Avg
3.76x
3Y Avg
3.76x
5Y Avg
2.29x
Market Cap
$90.37M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$90.64M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atara Biotherapeutics, Inc. (ATRA) | $87.85M | 9.46x | -6.46x | -20.94x | -19.23x |
| CareCloud, Inc. (CCLD)vs › | $87.96M | 40.06x | 25.10x | 22.17x | 18.57x |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $87.27M | -74.92x | N/A | N/A | N/A |
| electroCore, Inc. (ECOR)vs › | $89.44M | -22.29x | N/A | N/A | N/A |
| Equillium, Inc. (EQ)vs › | $89.78M | N/A | N/A | N/A | N/A |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $85.86M | N/A | N/A | N/A | N/A |
| ImmuCell Corporation (ICCC)vs › | $90.20M | 3.76x | 3.76x | 3.76x | 2.29x |
| Biomea Fusion, Inc. (BMEA)vs › | $90.37M | N/A | N/A | N/A | N/A |
| Rallybio Corporation (RLYB)vs › | $90.64M | N/A | N/A | N/A | N/A |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.13M | -3676.85x | N/A | N/A | N/A |
Interest Coverage
9.5x
Debt/Equity
N/A
Current Ratio
1.98
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -24.71x |
| 2026-03-31 | -4.06x |
| 2025-12-31 | -2.87x |
| 2025-09-30 | -3.93x |
| 2025-06-30 | 3.29x |
| 2025-03-31 | 38.15x |
| 2024-12-31 | -12.00x |
| 2024-09-30 | -18.39x |
| 2024-06-30 | -14.45x |
| 2024-03-31 | -27.10x |
| 2023-12-31 | -45.30x |
| 2023-09-30 | -49.90x |
| 2023-06-30 | -51.82x |
| 2023-03-31 | -56.15x |
| 2022-09-30 | -687.98x |
| 2022-06-30 | -249.09x |
| 2022-03-31 | -22055.00x |
| 2021-03-31 | -869.39x |
